Cover Image
市場調查報告書

Futura Medical Plc的產品平台分析

Futura Medical Plc - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 253769
出版日期 內容資訊 英文 27 Pages
訂單完成後即時交付
價格
Back to Top
Futura Medical Plc的產品平台分析 Futura Medical Plc - Product Pipeline Review - 2015
出版日期: 2015年07月15日 內容資訊: 英文 27 Pages
簡介

本報告提供Futura Medical Plc的產品開發平台現狀及各開發階段比較分析,提供您藥物簡介,開發平台的分析與最新趨勢,暫停中的計劃等資訊。

Futura Medical Plc的基本資料

Futura Medical Plc概要

  • 主要資訊
  • 企業資料

Futura Medical Plc:R&D概要

  • 主要的治療範圍

Futura Medical Plc:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Futura Medical Plc:開發中產品概況

  • 後期開發中產品
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式

Futura Medical Plc:藥物簡介

  • diclofenac sodium
  • ibuprofen
  • nitroglycerin
  • SPR-300

Futura Medical Plc:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Futura Medical Plc:最近的開發平台趨勢

Futura Medical Plc:暫停中的計劃

Futura Medical Plc:企業發表

Futura Medical Plc:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07327CDB

Summary

Global Markets Direct's, 'Futura Medical plc - Product Pipeline Review - 2015', provides an overview of the Futura Medical plc's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Futura Medical plc's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Futura Medical plc including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Futura Medical plc's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Futura Medical plc's pipeline products

Reasons to buy

  • Evaluate Futura Medical plc's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Futura Medical plc in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Futura Medical plc's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Futura Medical plc and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Futura Medical plc
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Futura Medical plc and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Futura Medical Plc Snapshot
    • Futura Medical Plc Overview
    • Key Information
    • Key Facts
  • Futura Medical Plc - Research and Development Overview
    • Key Therapeutic Areas
  • Futura Medical Plc - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Futura Medical Plc - Pipeline Products Glance
    • Futura Medical Plc - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Futura Medical Plc - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
  • Futura Medical Plc - Drug Profiles
    • diclofenac sodium
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ibuprofen
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • nitroglycerin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SPR-300
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Futura Medical Plc - Pipeline Analysis
    • Futura Medical Plc - Pipeline Products by Target
    • Futura Medical Plc - Pipeline Products by Route of Administration
    • Futura Medical Plc - Pipeline Products by Molecule Type
    • Futura Medical Plc - Pipeline Products by Mechanism of Action
  • Futura Medical Plc - Recent Pipeline Updates
  • Futura Medical Plc - Dormant Projects
  • Futura Medical Plc - Company Statement
  • Futura Medical Plc - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Futura Medical Plc, Key Information
  • Futura Medical Plc, Key Facts
  • Futura Medical Plc - Pipeline by Indication, 2015
  • Futura Medical Plc - Pipeline by Stage of Development, 2015
  • Futura Medical Plc - Monotherapy Products in Pipeline, 2015
  • Futura Medical Plc - Phase III, 2015
  • Futura Medical Plc - Phase II, 2015
  • Futura Medical Plc - Phase I, 2015
  • Futura Medical Plc - Pipeline by Target, 2015
  • Futura Medical Plc - Pipeline by Route of Administration, 2015
  • Futura Medical Plc - Pipeline by Molecule Type, 2015
  • Futura Medical Plc - Pipeline Products by Mechanism of Action, 2015
  • Futura Medical Plc - Recent Pipeline Updates, 2015
  • Futura Medical Plc - Dormant Developmental Projects,2015
  • Futura Medical Plc, Subsidiaries

List of Figures

  • Futura Medical Plc - Pipeline by Top 10 Indication, 2015
  • Futura Medical Plc - Pipeline by Stage of Development, 2015
  • Futura Medical Plc - Monotherapy Products in Pipeline, 2015
  • Futura Medical Plc - Pipeline by Top 10 Target, 2015
  • Futura Medical Plc - Pipeline by Top 10 Route of Administration, 2015
  • Futura Medical Plc - Pipeline by Top 10 Molecule Type, 2015
  • Futura Medical Plc - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top